← Back to Search

Personalized Care Strategies for Anxiety Disorders

N/A
Waitlist Available
Led By Shannon Sauer-Zavala
Research Sponsored by Shannon E. Sauer-Zavala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
diagnosis of at least one anxiety disorder, trauma- or stressor-related disorder, or obsessive-compulsive disorder
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks (baseline, week 1, week, 2, week, 3.....week 12)
Awards & highlights

Study Summary

This trial will test if a new way of delivering treatment to people with anxiety disorders is feasible, tolerable, and acceptable. It will also test if this new way is more efficient than the standard way of delivering treatment.

Who is the study for?
This trial is for individuals fluent in English who have been diagnosed with anxiety, traumatic stress disorders, PTSD, or OCD and are on stable medication. It's not suitable for those currently in therapy, who've had extensive cognitive behavioral therapy recently, or need alternative psychological treatments.Check my eligibility
What is being tested?
The study tests personalized treatment delivery to improve care efficiency for mental health conditions. Participants will try different sequences of the UP Treatment—standard order, capitalizing strengths or compensating weaknesses—and may stop early to assess change.See study design
What are the potential side effects?
Since this is a psychological treatment trial focusing on therapy sequencing rather than medication side effects might include discomfort during sessions, emotional distress from confronting difficult topics and potential temporary increase in symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with an anxiety, trauma-related, or obsessive-compulsive disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks (baseline, week 1, week, 2, week, 3.....week 12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks (baseline, week 1, week, 2, week, 3.....week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Clinical Severity
Change in Clinician-Rated Anxiety Symptoms
Change in Clinician-Rated Depressive Symptoms
+3 more

Trial Design

6Treatment groups
Experimental Treatment
Group I: Standard Group, Full InterventionExperimental Treatment1 Intervention
Participants in this group will receive 12 sessions of treatment in accordance with the standard, published Unified Protocol (UP) manual.
Group II: Standard Group, Brief InterventionExperimental Treatment1 Intervention
Participants in this group will receive 6 sessions of treatment in accordance with the standard, published Unified Protocol (UP) manual.
Group III: Compensation Group, Full InterventionExperimental Treatment1 Intervention
Participants in this group will receive 12 sessions of treatment organized to prioritize skills that compensate for patient weaknesses.
Group IV: Compensation Group, Brief InterventionExperimental Treatment1 Intervention
Participants in this group will receive 6 sessions of treatment organized to prioritize skills that compensate for patient weaknesses.
Group V: Capitalization Group, Full InterventionExperimental Treatment1 Intervention
Participants in this group will receive 12 sessions of treatment organized to prioritize skills that capitalize on patient strengths.
Group VI: Capitalization Group, Brief InterventionExperimental Treatment1 Intervention
Participants in this group will receive 6 sessions of treatment organized to prioritize skills that capitalize on patient strengths.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Capitalization UP Treatment
2019
N/A
~80
Standard UP Treatment
2019
N/A
~80
Compensation UP Treatment
2019
N/A
~80

Find a Location

Who is running the clinical trial?

Shannon E. Sauer-ZavalaLead Sponsor
4 Previous Clinical Trials
270 Total Patients Enrolled
1 Trials studying Obsessive-Compulsive Disorder
72 Patients Enrolled for Obsessive-Compulsive Disorder
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,041 Total Patients Enrolled
65 Trials studying Obsessive-Compulsive Disorder
13,915 Patients Enrolled for Obsessive-Compulsive Disorder
Shannon Sauer-ZavalaPrincipal InvestigatorUniversity of Kentucky
2 Previous Clinical Trials
112 Total Patients Enrolled
1 Trials studying Obsessive-Compulsive Disorder
72 Patients Enrolled for Obsessive-Compulsive Disorder

Media Library

Capitalization UP Treatment Clinical Trial Eligibility Overview. Trial Name: NCT04642898 — N/A
Obsessive-Compulsive Disorder Research Study Groups: Capitalization Group, Full Intervention, Standard Group, Brief Intervention, Compensation Group, Full Intervention, Capitalization Group, Brief Intervention, Compensation Group, Brief Intervention, Standard Group, Full Intervention
Obsessive-Compulsive Disorder Clinical Trial 2023: Capitalization UP Treatment Highlights & Side Effects. Trial Name: NCT04642898 — N/A
Capitalization UP Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04642898 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for volunteers in this trial?

"Correct. According to information located on clinicaltrials.gov, this medical trial is presently recruiting patients and was first advertised in June of 2021. As it stands, 66 participants are required from a single site with the latest update occurring September 26th 2022."

Answered by AI

What is the current population of subjects participating in this research?

"Affirmative. Clinicaltrials.gov hosts information that confirms this medical trial is recruiting participants; it was first announced on June 22nd 2021 and subsequently updated on September 26th 2022. 66 patients need to be enrolled from 1 particular location for the study to continue."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
University of Kentucky

Why did patients apply to this trial?

I enjoy helping and in hopes of getting help. I would like to find a way to help me more.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Increasing Treatment Efficacy Using SMART Methods for Personalizing Care
Shannon E. Sauer-Zavala 2021. "Increasing Treatment Efficacy Using SMART Methods for Personalizing Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04642898.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top